Physician Wealth Solutions Inc. boosted its holdings in shares of Avantis Emerging Markets Equity ETF (NYSEARCA:AVEM – Free Report) by 10.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 55,511 shares of the company’s stock after buying an additional 5,051 shares during the quarter. Avantis Emerging Markets Equity ETF makes up about 1.6% of Physician Wealth Solutions Inc.’s investment portfolio, making the stock its 18th largest holding. Physician Wealth Solutions Inc. owned approximately 0.06% of Avantis Emerging Markets Equity ETF worth $3,263,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in AVEM. First Trust Direct Indexing L.P. bought a new stake in Avantis Emerging Markets Equity ETF during the third quarter valued at approximately $331,000. Gladstone Institutional Advisory LLC bought a new position in shares of Avantis Emerging Markets Equity ETF in the third quarter worth approximately $205,000. Angeles Wealth Management LLC boosted its position in shares of Avantis Emerging Markets Equity ETF by 1,479.2% in the third quarter. Angeles Wealth Management LLC now owns 3,648 shares of the company’s stock worth $236,000 after purchasing an additional 3,417 shares during the period. Forum Financial Management LP boosted its position in shares of Avantis Emerging Markets Equity ETF by 25.7% in the third quarter. Forum Financial Management LP now owns 17,098 shares of the company’s stock worth $1,105,000 after purchasing an additional 3,493 shares during the period. Finally, Highland Financial Advisors LLC boosted its position in shares of Avantis Emerging Markets Equity ETF by 1.2% in the third quarter. Highland Financial Advisors LLC now owns 94,442 shares of the company’s stock worth $6,101,000 after purchasing an additional 1,088 shares during the period.
Avantis Emerging Markets Equity ETF Price Performance
AVEM opened at $58.70 on Tuesday. The firm has a market cap of $7.35 billion, a P/E ratio of 11.90 and a beta of 0.78. Avantis Emerging Markets Equity ETF has a 1-year low of $55.65 and a 1-year high of $66.31. The company has a 50 day simple moving average of $59.59 and a two-hundred day simple moving average of $61.26.
Avantis Emerging Markets Equity ETF Company Profile
The Avantis Emerging Markets Equity ETF (AVEM) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund that holds emerging-market stocks of all market capitalizations considered favorable on multiple factors. The fund seeks to provide capital appreciation.
Featured Stories
- Five stocks we like better than Avantis Emerging Markets Equity ETF
- The Significance of Brokerage Rankings in Stock Selection
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- The 3 Best Retail Stocks to Shop for in August
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Want to see what other hedge funds are holding AVEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantis Emerging Markets Equity ETF (NYSEARCA:AVEM – Free Report).
Receive News & Ratings for Avantis Emerging Markets Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantis Emerging Markets Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.